While trials with decentralized attributes have grown, we are still in the early stages of adapting trial design strategies to better fit this new reality. This white paper explores the current DCT landscape and its evolution over time, as well as the key advantages of incorporating decentralized attributes and how barriers to their inclusion can be overcome.

We need to make trials fit around lives rather than lives fit around trials.
Wendi Lau, Senior Director of Clinical Development Operations, AbbVie

Related resources

Decentralized clinical trials_resource-card-thumbnail
OCT 11, 2023
Article
Clinical

Decentralized Clinical Trials - Meeting Patients Where They’re At

Decentralized clinical trials are one example of how the research community is working to make trials as accessible as possible.

Medtech-Insight-podcast_resource-card-thumbnail
JUL 03, 2023
Podcast
Commercial

Medtech Connect Podcast Episode 7 – Decentralized Clinical Trials

Decentralized clinical trial experts discuss the draft FDA guidance, what might need clarification, and what changes they expect as DCTs become mainstream.

holographic image of people walking
SEP 06, 2023
Article
Clinical

Technology & the Triple Aim of Trial Recruiting

The search for a clinical trial match has led patients and caregivers online. All stakeholders must be connected and vetted via available technology.